Global and United States Next-Generation Drug-Eluting Stent Market Report & Forecast 2023-2028

Report ID: 1860754 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Next-Generation Drug-Eluting Stent Product Introduction
    1.2 Global Next-Generation Drug-Eluting Stent Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Next-Generation Drug-Eluting Stent Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Next-Generation Drug-Eluting Stent Sales in Volume for the Year 2017-2028
    1.3 United States Next-Generation Drug-Eluting Stent Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Next-Generation Drug-Eluting Stent Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Next-Generation Drug-Eluting Stent Sales in Volume for the Year 2017-2028
    1.4 Next-Generation Drug-Eluting Stent Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Next-Generation Drug-Eluting Stent in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Next-Generation Drug-Eluting Stent Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Next-Generation Drug-Eluting Stent Market Dynamics
        1.5.1 Next-Generation Drug-Eluting Stent Industry Trends
        1.5.2 Next-Generation Drug-Eluting Stent Market Drivers
        1.5.3 Next-Generation Drug-Eluting Stent Market Challenges
        1.5.4 Next-Generation Drug-Eluting Stent Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Next-Generation Drug-Eluting Stent Market Segment by Type
        2.1.1 Cobalt Chromium
        2.1.2 Stainless Steel
        2.1.3 Others
    2.2 Global Next-Generation Drug-Eluting Stent Market Size by Type
        2.2.1 Global Next-Generation Drug-Eluting Stent Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Next-Generation Drug-Eluting Stent Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Next-Generation Drug-Eluting Stent Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Next-Generation Drug-Eluting Stent Market Size by Type
        2.3.1 United States Next-Generation Drug-Eluting Stent Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Next-Generation Drug-Eluting Stent Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Next-Generation Drug-Eluting Stent Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Next-Generation Drug-Eluting Stent Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Ambulatory Surgical Centers
    3.2 Global Next-Generation Drug-Eluting Stent Market Size by Application
        3.2.1 Global Next-Generation Drug-Eluting Stent Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Next-Generation Drug-Eluting Stent Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Next-Generation Drug-Eluting Stent Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Next-Generation Drug-Eluting Stent Market Size by Application
        3.3.1 United States Next-Generation Drug-Eluting Stent Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Next-Generation Drug-Eluting Stent Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Next-Generation Drug-Eluting Stent Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Next-Generation Drug-Eluting Stent Competitor Landscape by Company
    4.1 Global Next-Generation Drug-Eluting Stent Market Size by Company
        4.1.1 Top Global Next-Generation Drug-Eluting Stent Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Next-Generation Drug-Eluting Stent Revenue by Manufacturer (2017-2022)
        4.1.3 Global Next-Generation Drug-Eluting Stent Sales by Manufacturer (2017-2022)
        4.1.4 Global Next-Generation Drug-Eluting Stent Price by Manufacturer (2017-2022)
    4.2 Global Next-Generation Drug-Eluting Stent Concentration Ratio (CR)
        4.2.1 Next-Generation Drug-Eluting Stent Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Next-Generation Drug-Eluting Stent in 2021
        4.2.3 Global Next-Generation Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Next-Generation Drug-Eluting Stent Manufacturing Base Distribution, Product Type
        4.3.1 Global Next-Generation Drug-Eluting Stent Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Next-Generation Drug-Eluting Stent Product Type
        4.3.3 Date of International Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Next-Generation Drug-Eluting Stent Market Size by Company
        4.5.1 Top Next-Generation Drug-Eluting Stent Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Next-Generation Drug-Eluting Stent Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Next-Generation Drug-Eluting Stent Sales by Players (2020, 2021 & 2022)
5 Global Next-Generation Drug-Eluting Stent Market Size by Region
    5.1 Global Next-Generation Drug-Eluting Stent Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Next-Generation Drug-Eluting Stent Market Size in Volume by Region (2017-2028)
        5.2.1 Global Next-Generation Drug-Eluting Stent Sales in Volume by Region: 2017-2022
        5.2.2 Global Next-Generation Drug-Eluting Stent Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Next-Generation Drug-Eluting Stent Market Size in Value by Region (2017-2028)
        5.3.1 Global Next-Generation Drug-Eluting Stent Sales in Value by Region: 2017-2022
        5.3.2 Global Next-Generation Drug-Eluting Stent Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Next-Generation Drug-Eluting Stent Market Size YoY Growth 2017-2028
        6.1.2 North America Next-Generation Drug-Eluting Stent Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Next-Generation Drug-Eluting Stent Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Next-Generation Drug-Eluting Stent Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Next-Generation Drug-Eluting Stent Market Size YoY Growth 2017-2028
        6.3.2 Europe Next-Generation Drug-Eluting Stent Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Next-Generation Drug-Eluting Stent Market Size YoY Growth 2017-2028
        6.4.2 Latin America Next-Generation Drug-Eluting Stent Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Next-Generation Drug-Eluting Stent Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Next-Generation Drug-Eluting Stent Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Corporation Information
        7.1.2 Abbott Description and Business Overview
        7.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Abbott Next-Generation Drug-Eluting Stent Products Offered
        7.1.5 Abbott Recent Development
    7.2 Biosensors International
        7.2.1 Biosensors International Corporation Information
        7.2.2 Biosensors International Description and Business Overview
        7.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Biosensors International Next-Generation Drug-Eluting Stent Products Offered
        7.2.5 Biosensors International Recent Development
    7.3 Medtronic
        7.3.1 Medtronic Corporation Information
        7.3.2 Medtronic Description and Business Overview
        7.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Medtronic Next-Generation Drug-Eluting Stent Products Offered
        7.3.5 Medtronic Recent Development
    7.4 Sorin Group
        7.4.1 Sorin Group Corporation Information
        7.4.2 Sorin Group Description and Business Overview
        7.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Sorin Group Next-Generation Drug-Eluting Stent Products Offered
        7.4.5 Sorin Group Recent Development
    7.5 SMT
        7.5.1 SMT Corporation Information
        7.5.2 SMT Description and Business Overview
        7.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 SMT Next-Generation Drug-Eluting Stent Products Offered
        7.5.5 SMT Recent Development
    7.6 Terumo
        7.6.1 Terumo Corporation Information
        7.6.2 Terumo Description and Business Overview
        7.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Terumo Next-Generation Drug-Eluting Stent Products Offered
        7.6.5 Terumo Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Next-Generation Drug-Eluting Stent Industry Chain Analysis
    8.2 Next-Generation Drug-Eluting Stent Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Next-Generation Drug-Eluting Stent Distributors
    8.3 Next-Generation Drug-Eluting Stent Production Mode & Process
    8.4 Next-Generation Drug-Eluting Stent Sales and Marketing
        8.4.1 Next-Generation Drug-Eluting Stent Sales Channels
        8.4.2 Next-Generation Drug-Eluting Stent Distributors
    8.5 Next-Generation Drug-Eluting Stent Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Next-Generation Drug-Eluting Stent CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Next-Generation Drug-Eluting Stent Market Trends
    Table 3. Next-Generation Drug-Eluting Stent Market Drivers
    Table 4. Next-Generation Drug-Eluting Stent Market Challenges
    Table 5. Next-Generation Drug-Eluting Stent Market Restraints
    Table 6. Global Next-Generation Drug-Eluting Stent Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Next-Generation Drug-Eluting Stent Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Next-Generation Drug-Eluting Stent Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Next-Generation Drug-Eluting Stent Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Next-Generation Drug-Eluting Stent Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Next-Generation Drug-Eluting Stent Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Next-Generation Drug-Eluting Stent Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Next-Generation Drug-Eluting Stent Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Next-Generation Drug-Eluting Stent Sales Share by Manufacturer, 2017-2022
    Table 15. Global Next-Generation Drug-Eluting Stent Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Next-Generation Drug-Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Next-Generation Drug-Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Drug-Eluting Stent as of 2021)
    Table 18. Top Players of Next-Generation Drug-Eluting Stent in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Next-Generation Drug-Eluting Stent Product Type
    Table 20. Date of International Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Next-Generation Drug-Eluting Stent Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Next-Generation Drug-Eluting Stent Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Next-Generation Drug-Eluting Stent Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Next-Generation Drug-Eluting Stent Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Next-Generation Drug-Eluting Stent Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Next-Generation Drug-Eluting Stent Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Next-Generation Drug-Eluting Stent Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Next-Generation Drug-Eluting Stent Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Next-Generation Drug-Eluting Stent Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Next-Generation Drug-Eluting Stent Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Next-Generation Drug-Eluting Stent Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Next-Generation Drug-Eluting Stent Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Next-Generation Drug-Eluting Stent Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Next-Generation Drug-Eluting Stent Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Next-Generation Drug-Eluting Stent Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Next-Generation Drug-Eluting Stent Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Next-Generation Drug-Eluting Stent Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Next-Generation Drug-Eluting Stent Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Next-Generation Drug-Eluting Stent Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Next-Generation Drug-Eluting Stent Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbott Corporation Information
    Table 43. Abbott Description and Business Overview
    Table 44. Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Abbott Next-Generation Drug-Eluting Stent Product
    Table 46. Abbott Recent Development
    Table 47. Biosensors International Corporation Information
    Table 48. Biosensors International Description and Business Overview
    Table 49. Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Biosensors International Product
    Table 51. Biosensors International Recent Development
    Table 52. Medtronic Corporation Information
    Table 53. Medtronic Description and Business Overview
    Table 54. Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Medtronic Product
    Table 56. Medtronic Recent Development
    Table 57. Sorin Group Corporation Information
    Table 58. Sorin Group Description and Business Overview
    Table 59. Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Sorin Group Product
    Table 61. Sorin Group Recent Development
    Table 62. SMT Corporation Information
    Table 63. SMT Description and Business Overview
    Table 64. SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. SMT Product
    Table 66. SMT Recent Development
    Table 67. Terumo Corporation Information
    Table 68. Terumo Description and Business Overview
    Table 69. Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Terumo Product
    Table 71. Terumo Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Next-Generation Drug-Eluting Stent Customers List
    Table 75. Next-Generation Drug-Eluting Stent Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Next-Generation Drug-Eluting Stent Product Picture
    Figure 2. Global Next-Generation Drug-Eluting Stent Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Next-Generation Drug-Eluting Stent Market Size 2017-2028 (US$ Million)
    Figure 4. Global Next-Generation Drug-Eluting Stent Sales 2017-2028 (K Units)
    Figure 5. United States Next-Generation Drug-Eluting Stent Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Next-Generation Drug-Eluting Stent Market Size 2017-2028 (US$ Million)
    Figure 7. United States Next-Generation Drug-Eluting Stent Sales 2017-2028 (K Units)
    Figure 8. United States Next-Generation Drug-Eluting Stent Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Next-Generation Drug-Eluting Stent Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Next-Generation Drug-Eluting Stent Report Years Considered
    Figure 11. Product Picture of Cobalt Chromium
    Figure 12. Product Picture of Stainless Steel
    Figure 13. Product Picture of Others
    Figure 14. Global Next-Generation Drug-Eluting Stent Market Share by Type in 2022 & 2028
    Figure 15. Global Next-Generation Drug-Eluting Stent Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Next-Generation Drug-Eluting Stent Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Next-Generation Drug-Eluting Stent Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Next-Generation Drug-Eluting Stent Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Next-Generation Drug-Eluting Stent Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Next-Generation Drug-Eluting Stent Market Share by Type in 2022 & 2028
    Figure 21. United States Next-Generation Drug-Eluting Stent Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Next-Generation Drug-Eluting Stent Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Next-Generation Drug-Eluting Stent Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Next-Generation Drug-Eluting Stent Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Next-Generation Drug-Eluting Stent Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Ambulatory Surgical Centers
    Figure 29. Global Next-Generation Drug-Eluting Stent Market Share by Application in 2022 & 2028
    Figure 30. Global Next-Generation Drug-Eluting Stent Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Next-Generation Drug-Eluting Stent Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Next-Generation Drug-Eluting Stent Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Next-Generation Drug-Eluting Stent Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Next-Generation Drug-Eluting Stent Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Next-Generation Drug-Eluting Stent Market Share by Application in 2022 & 2028
    Figure 36. United States Next-Generation Drug-Eluting Stent Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Next-Generation Drug-Eluting Stent Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Next-Generation Drug-Eluting Stent Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Next-Generation Drug-Eluting Stent Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Next-Generation Drug-Eluting Stent Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Next-Generation Drug-Eluting Stent Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Next-Generation Drug-Eluting Stent Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Next-Generation Drug-Eluting Stent Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Next-Generation Drug-Eluting Stent Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Next-Generation Drug-Eluting Stent Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Next-Generation Drug-Eluting Stent Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Next-Generation Drug-Eluting Stent Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Next-Generation Drug-Eluting Stent Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Next-Generation Drug-Eluting Stent Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Next-Generation Drug-Eluting Stent Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Next-Generation Drug-Eluting Stent Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Next-Generation Drug-Eluting Stent Value Chain
    Figure 75. Next-Generation Drug-Eluting Stent Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
Frequently Asked Questions
Next-Generation Drug-Eluting Stent report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Next-Generation Drug-Eluting Stent report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Next-Generation Drug-Eluting Stent report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports